Dahlia Morovati Amitai is a pharmacist who is specialized in Ambulatory Care in Sylmar, California. Patients can reach her at 14445 Olive View Dr, Sylmar or contact her on 747-210-3000. Active license number of Dahlia Morovati Amitai is 82536 for Ambulatory Care in California. Dahlia Morovati Amitai is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Dahlia Morovati Amitai speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dahlia Morovati Amitai are as mentioned below.
NPI Number:
1023635919
NPI Enumeration Date:
26 Jun, 2020
NPI Last Update On:
21 Jan, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dahlia Morovati Amitai are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
82536
California
Primary
Student In An Organized Health Care Education/training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5323 Blanco Ave, Woodland Hills, California
Zip:
91367-5711
Phone Number:
818-389-4573
Fax Number:
--
Patients can reach Dahlia Morovati Amitai at 14445 Olive View Dr, Sylmar, California or can call on phone at 747-210-3000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.